193 related articles for article (PubMed ID: 31702673)
21. A polyphenol fraction from Rosa multiflora var. platyphylala reduces body fat in overweight humans through appetite suppression - a randomized, double-blind, placebo-controlled trial.
Sudeep HV; Prithviraj P; Jestin TV; Shyamprasad K
BMC Complement Med Ther; 2024 May; 24(1):197. PubMed ID: 38773474
[TBL] [Abstract][Full Text] [Related]
22. Matured hop extract reduces body fat in healthy overweight humans: a randomized, double-blind, placebo-controlled parallel group study.
Morimoto-Kobayashi Y; Ohara K; Ashigai H; Kanaya T; Koizumi K; Manabe F; Kaneko Y; Taniguchi Y; Katayama M; Kowatari Y; Kondo S
Nutr J; 2016 Mar; 15():25. PubMed ID: 26960416
[TBL] [Abstract][Full Text] [Related]
23. A pilot study exploring the efficacy and safety of herbal medicine on Korean obese women with metabolic syndrome risk factors: Double blinded, randomized, multicenter, placebo controlled study protocol clinical trial.
Kim HJ; Ko Y; Kim H; Cha YY; Jang BH; Song YK; Ko SG
Medicine (Baltimore); 2020 Jan; 99(5):e18955. PubMed ID: 32000419
[TBL] [Abstract][Full Text] [Related]
24. A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial.
Fidler MC; Sanchez M; Raether B; Weissman NJ; Smith SR; Shanahan WR; Anderson CM;
J Clin Endocrinol Metab; 2011 Oct; 96(10):3067-77. PubMed ID: 21795446
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of HT080 for lower urinary tract symptoms associated with benign prostatic hyperplasia: A study protocol for a randomized, double-blind, placebo-controlled trial.
Song J; Lee SH; Kim H
Medicine (Baltimore); 2019 Nov; 98(45):e17848. PubMed ID: 31702643
[TBL] [Abstract][Full Text] [Related]
26. Danggwijagyaksan for climacteric syndrome in peri- and postmenopausal women with a blood-deficiency dominant pattern: study protocol for a randomized, double-blind, placebo-controlled pilot trial.
Kim M; Kim AR; Park HJ; Kwon O; Kim JH; Park EJ; Baek SE; Yoo JE; Lee JH
Trials; 2018 Jan; 19(1):41. PubMed ID: 29335018
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of Jujadokseo-hwan for memory deficit (amnesia) in mild neurocognitive disorder: A protocol for randomized, double-blind, placebo-controlled, parallel-group, multicenter clinical trial.
Jeong JH; Lee JY; Kim JY; Seo YK; Kang WC; Kang HW; Park SJ; Jang HK; Park YC; Jung IC
Medicine (Baltimore); 2020 Feb; 99(8):e19231. PubMed ID: 32080123
[TBL] [Abstract][Full Text] [Related]
28. A Preliminary Study for Evaluating the Dose-Dependent Effect of d-Allulose for Fat Mass Reduction in Adult Humans: A Randomized, Double-Blind, Placebo-Controlled Trial.
Han Y; Kwon EY; Yu MK; Lee SJ; Kim HJ; Kim SB; Kim YH; Choi MS
Nutrients; 2018 Jan; 10(2):. PubMed ID: 29385054
[TBL] [Abstract][Full Text] [Related]
29. Exploring the efficacy and safety of herbal medicine on Korean obese women with or without metabolic syndrome risk factors: A study protocol for a double-blind, randomized, multi-center, placebo-controlled clinical trial.
Ko Y; Kim HJ; Kim H; Choi JB; Kwon YD; Jung WS; Jang BH; Kim N; Song YK; Ko SG
Medicine (Baltimore); 2020 Jul; 99(28):e21153. PubMed ID: 32664149
[TBL] [Abstract][Full Text] [Related]
30. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial.
Wadden TA; Bailey TS; Billings LK; Davies M; Frias JP; Koroleva A; Lingvay I; O'Neil PM; Rubino DM; Skovgaard D; Wallenstein SOR; Garvey WT;
JAMA; 2021 Apr; 325(14):1403-1413. PubMed ID: 33625476
[TBL] [Abstract][Full Text] [Related]
31. Investigating the safety and efficacy of naltrexone for anti-psychotic induced weight gain in severe mental illness: study protocol of a double-blind, randomized, placebo-controlled trial.
Tek C; Guloksuz S; Srihari VH; Reutenauer EL
BMC Psychiatry; 2013 Jun; 13():176. PubMed ID: 23805859
[TBL] [Abstract][Full Text] [Related]
32. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Greenway FL; Fujioka K; Plodkowski RA; Mudaliar S; Guttadauria M; Erickson J; Kim DD; Dunayevich E;
Lancet; 2010 Aug; 376(9741):595-605. PubMed ID: 20673995
[TBL] [Abstract][Full Text] [Related]
33. A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment.
Coffey CS; Steiner D; Baker BA; Allison DB
Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1411-9. PubMed ID: 15356670
[TBL] [Abstract][Full Text] [Related]
34. Effect of Steamed Onion (ONIRO) Consumption on Body Fat and Metabolic Profiles in Overweight Subjects: A 12-Week Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Jeong S; Chae J; Lee G; Shin G; Kwon YI; Oh JB; Shin DY; Lee JH
J Am Coll Nutr; 2020; 39(3):206-215. PubMed ID: 31368861
[No Abstract] [Full Text] [Related]
35. Effects of oral Nigella sativa oil on the expression levels and serum concentrations of adiponectin, PPAR-γ, and TNF-α in overweight and obese women: a study protocol for a crossover-designed, double-blind, placebo-controlled randomized clinical trial.
Razmpoosh E; Safi S; Mazaheri M; Salehi-Abargouei A; Abdollahi N; Nazari M; Fallahzadeh H; Nadjarzadeh A
Trials; 2019 Aug; 20(1):512. PubMed ID: 31420057
[TBL] [Abstract][Full Text] [Related]
36. Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study.
Finer N; Bloom SR; Frost GS; Banks LM; Griffiths J
Diabetes Obes Metab; 2000 Apr; 2(2):105-12. PubMed ID: 11220522
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of Euiiyin-tang in Korean women with obesity: A randomized, double-blind, placebo-controlled, multicenter trial.
Cheon C; Song YK; Ko SG
Complement Ther Med; 2020 Jun; 51():102423. PubMed ID: 32507436
[TBL] [Abstract][Full Text] [Related]
38. Weight reduction effects of a black soy peptide supplement in overweight and obese subjects: double blind, randomized, controlled study.
Kwak JH; Ahn CW; Park SH; Jung SU; Min BJ; Kim OY; Lee JH
Food Funct; 2012 Oct; 3(10):1019-24. PubMed ID: 22739624
[TBL] [Abstract][Full Text] [Related]
39. Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects.
Sneve M; Figenschau Y; Jorde R
Eur J Endocrinol; 2008 Dec; 159(6):675-84. PubMed ID: 19056900
[TBL] [Abstract][Full Text] [Related]
40. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
